Answers are grounded in this paper and cite their sources.
Tuberculosis after recovering from COVID-19 is becoming more common, potentially leading to a TB outbreak in the post-COVID-19 era. The immunosuppressive nature of the disease and its treatment modalities may contribute to post COVID-19 TB. Thus, we recommend a further study with a large sample size. Furthermore, we recommend feasibility studies to assess and treat latent TB in COVID-19 patients residing in TB endemic counties since treatment of latent TB is done only in TB non-endemic countries.
No takes yet. Share an insight, caveat, or question.
Alemu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: